• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OPSENS OPTOWIRE III; CORONARY PRESSURE GUIDEWIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OPSENS OPTOWIRE III; CORONARY PRESSURE GUIDEWIRE Back to Search Results
Model Number F1034
Device Problems Fracture (1260); Detachment of Device or Device Component (2907)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/19/2020
Event Type  malfunction  
Manufacturer Narrative
Investigation of the returned optowire iii by the market authorization holder confirmed that the guidewire was fractured at 300mm from its distal end, in the proximal joint of the shaft portion of the device.The characteristics of the fracture indicated that the guidewire broke from fatigue.The guidewire would have failed from repeated pull/push during the attempt the cross the tortuous vessel.No sign of excessive torsion or kink was observed on the guidewire.Based on the narrative and results from investigation, it is estimated that the repeated attempts to cross the tortuous lesion, combined with the use of a diagnostic catheter in place of the recommended guiding catheter, led to the fracture by fatigue of the guidewire's shaft.The cause of the failure is likely related to the usage of the device beyond the recommendations provided in the instructions for use (ifu).Review of device history record confirmed that the optowire lot was released per specifications.No link was established between the incident and the deviations documented on the optowire lot.The investigation did not identify any new risk.The risks associated with the event are disclosed in the optowire iii instructions for use (ifu): if resistance occurs and the cause of resistance cannot be determined, do not move or torque the optowire.Stop the procedure, determine the cause of resistance under fluoroscopy and take appropriate action.Optowire should be manipulated only under fluoroscopy.Care should be taken when manipulating a guidewire inside a vessel during device placement and removal.Observe optowire movement in the vessels.Before an optowire is moved or torqued, the tip movement should be examined under fluoroscopy.Do not torque an optowire without observing corresponding movement of the tip.Otherwise, vessel trauma may occur.Never advance an optowire against resistance without first determining the reason for the resistance under fluoroscopy.Excessive force against resistance may result in damage to the wire, and/or to the vessel.If resistance occurs and the cause of resistance cannot be determined, do not move, or torque the optowire.Stop the procedure, determine the cause of resistance under fluoroscopy and take appropriate action.Do not use the optowire if any portion of the device or packaging appears damaged, if any portion of the sterile pouch has been opened or if product is expired.Confirm the compatibility of the guidewire diameter with the interventional device before actual use.A corrective action request was already put in place by the manufacturer.No additional action intended as a result of the incident.
 
Event Description
Angiography catheter 5f jl3.5 was used to evaluate ffr / dpr with optowire3.There was strong meandering in the coronary artery (lcx #13) to be accessed, and it was difficult to insert optowire 3.There was a feeling of strangeness in the operation, and when optowire3 was pulled out, it was a fractured near the joint between the shaft and core.Therefore, kusabi (balloon catheter) was inserted into the angiography catheter 5f, and the tip part left in the coronary artery was retrieved.After that, the procedure was completed using the new optowire3.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTOWIRE III
Type of Device
CORONARY PRESSURE GUIDEWIRE
Manufacturer (Section D)
OPSENS
750
boulevard parc technologique
quebec, quebec G1P 4 S3
CA  G1P 4S3
Manufacturer Contact
samuel magnan
750
boulevard parc technologique
quebec, quebec G1P 4-S3
CA   G1P 4S3
MDR Report Key11031932
MDR Text Key223807901
Report Number3008061490-2020-00007
Device Sequence Number1
Product Code DXO
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K191907
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,health profession
Reporter Occupation Physician
Type of Report Initial
Report Date 11/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2023
Device Model NumberF1034
Device Lot NumberOW-2051D
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/24/2020
Initial Date FDA Received12/17/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/09/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-